LINDSAY NORDMEYER: Open Payments
NPI 1487291498 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 29 payments from 15 companies in 2025. Trend: 2023 $498 · 2024 $626 · 2025 $645
Food & beverage: $553Education: $92
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $125 |
| Daiichi Sankyo Inc. | 6 | $100 |
| Gilead Sciences, Inc. | 1 | $92 |
| Iovance Biotherapeutics, Inc. | 3 | $43 |
| Novartis Pharmaceuticals Corporation | 3 | $41 |
| Geron Corporation | 2 | $36 |
| Janssen Biotech, Inc. | 2 | $36 |
| GENZYME CORPORATION | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| JAZZ PHARMACEUTICALS INC. | 2 | $28 |
Products named: Jakafi, Trodelvy, Enhertu, DATROWAY, Amtagvi, RYTELO, RYBREVANT, LIBTAYO.
Industry payments across AR — which companies pay providers there.
